Weeberb J. Requia and Moataz Mahmoud are with McMaster University, McMaster Institute for Transportation and Logistics, Hamilton, Ontario, Canada. Matthew D. Adams is with Ryerson University, Department of Geography and Environmental Studies, Toronto, Ontario. Altaf Arain is with McMaster University, School of Geography and Earth Sciences, Hamilton. Stefania Papatheodorou is with Cyprus University of Technology, Cyprus International Institute for Environmental and Public Health, Limassol, Cyprus. Petros Koutrakis is with Harvard University, Harvard T. H. Chan School of Public Health, Boston, MA.
Checking for direct PDF access through Ovid
BackgroundLittle is known about the health risks of air pollution and cardiorespiratory diseases, globally, across regions and populations, which may differ because of external factors.ObjectivesWe systematically reviewed the evidence on the association between air pollution and cardiorespiratory diseases (hospital admissions and mortality), including variability by energy, transportation, socioeconomic status, and air quality.Search MethodsWe conducted a literature search (PubMed and Web of Science) for studies published between 2006 and May 11, 2016.Selection CriteriaWe included studies if they met all of the following criteria: (1) considered at least 1 of these air pollutants: carbon monoxide, sulfur dioxide, nitrogen dioxide, ozone, or particulate matter (PM2.5 or PM10); (2) reported risk for hospital admissions, mortality, or both; (3) presented individual results for respiratory diseases, cardiovascular diseases, or both; (4) considered the age groups younger than 5 years, older than 65 years, or all ages; and (5) did not segregate the analysis by gender.Data Collection and AnalysisWe extracted data from each study, including location, health outcome, and risk estimates. We performed a meta-analysis to estimate the overall effect and to account for both within- and between-study heterogeneity. Then, we applied a model selection (least absolute shrinkage and selection operator) to assess the modifier variables, and, lastly, we performed meta-regression analyses to evaluate the modifier variables contributing to heterogeneity among studies.Main ResultsWe assessed 2183 studies, of which we selected 529 for in-depth review, and 70 articles fulfilled our study inclusion criteria. The 70 studies selected for meta-analysis encompass more than 30 million events across 28 countries. We found positive associations between cardiorespiratory diseases and different air pollutants. For example, when we considered only the association between PM2.5 and respiratory diseases (Figure 1, we observed a risk equal to 2.7% (95% confidence interval = 0.9%, 7.7%). Our results showed statistical significance in the test of moderators for all pollutants, suggesting that the modifier variables influence the average cardiorespiratory disease risk and may explain the varying effects of air pollution.ConclusionsVariables related to aspects of energy, transportation, and socioeconomic status may explain the varying effect size of the association between air pollution and cardiorespiratory diseases.Public Health ImplicationsOur study provides a transferable model to estimate the health effects of air pollutants to support the creation of environmental health public policies for national and international intervention.